Target intelligence / Profile preview

Major curlin subunit (CsgA) (CsgA)

Target
CsgA
Molecular classification
Structural amyloid protein, Intrinsically disordered protein (IDP) that assembles into functional amyloid fibers, Contains five imperfect repeats (R1-R5) with the consensus sequence S–X5–Q–X–G–X–G–N–X–A–X3–Q that are amyloidogenic
01

Overview

CsgA (major curlin subunit) is the primary structural component of curli, functional amyloid fibers produced on the surface of gram-negative bacteria, particularly *Escherichia coli*[1][2]. Upon secretion through the outer membrane CsgG–CsgE–CsgF complex, CsgA monomers are nucleated by the minor subunit CsgB and assemble into a non-centrosymmetric beta-helical fibril architecture stabilized by hydrogen bonding between five amyloidogenic repeats[1][3]. These curli fibers are integral to bacterial biofilm formation, enabling cell adhesion, surface colonization, and host invasion[2][3]. While CsgA itself is not a therapeutic target in the traditional sense, understanding its structure and assembly mechanisms provides insights relevant to preventing biofilm-associated infections and potentially developing novel anti-biofilm strategies. Additionally, CsgA serves as a model for studying regulated functional amyloid production, with implications for understanding pathological amyloid diseases in humans[2].

Other names
Curlin major subunitCurli fiber proteinStructural subunit of curli fimbriae
02

Mechanism of action

CsgA assembly involves: - Nucleation-precipitation mechanism: Unfolded CsgA subunits in solution are nucleated by CsgB (minor subunit), causing ordered assembly into fibers in the extracellular space - Secretion via Type VIII system: CsgA is secreted through the CsgG–CsgE–CsgF complex (outer membrane pore), where accessory proteins CsgE and CsgF regulate controlled export - Chaperone regulation: CsgC (periplasmic chaperone) and CsgE (secretion chaperone) prevent premature amyloid formation and direct CsgA toward secretion - Electrostatic interactions: CsgA contains 10 acidic amino acids and only 4 basic amino acids, enabling negatively charged surface interactions with positively charged regions of chaperone proteins

03

Biological functions

Biofilm formation: CsgA is the major structural component (~80-90% composition) of curli amyloid fibers, which form part of the extracellular biofilm matrix in gram-negative bacteriaCell adhesion: Curli fibers facilitate bacterial attachment to surfaces and host cellsBacterial colonization: Curli enhance bacterial persistence and virulenceStructural architecture: CsgA adopts a non-centrosymmetric beta-helical structure within fibrils, with 7-8 CsgA monomers per fibril unit showing high stability and uniformity
04

Disease associations

Bacterial infection: Curli-producing pathogens (primarily *Escherichia coli*) use CsgA-containing biofilms to establish persistent infections and evade immune responsesBiofilm-related infections: CsgA is implicated in catheter-associated infections, urinary tract infections, and other biofilm-dependent pathologies
05

Safety considerations

Not a traditional drug target: CsgA is a bacterial structural protein, not a mammalian receptor or enzyme, limiting conventional small-molecule drug development approachesBiofilm resistance: CsgA-containing biofilms provide protection against antibiotics and immune responses, making infections difficult to treatModel amyloid protein: CsgA shares structural similarities with pathogenic human amyloids (e.g., alpha-synuclein in Parkinson's disease), but targeting bacterial CsgA would not directly address human amyloidoses
06

Interacting drugs

No direct therapeutic drugs targeting CsgA are currently approved or widely documented. However, understanding CsgA structure could inform development of biofilm-disrupting agents or anti-adhesion therapies.
07

Biomarkers

CsgA presence/abundance in biofilm samples could serve as a marker for bacterial biofilm maturity and virulence potentialCsgA-specific antibodies in patient sera might indicate chronic infection by curli-producing pathogens

Beyond the preview

Go deeper on Major curlin subunit (CsgA) (CsgA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major curlin subunit (CsgA) (CsgA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call